Clincosm LogoSign in Get a demo

neuroendocrine tumors

Showing 76 - 100 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)

Not yet recruiting
  • Neuroendocrine Tumors
  • Göteborg, Sweden
  • +3 more
May 19, 2022

Neuroendocrine Neoplasms Methylation Based Classifier - The

Enrolling by invitation
  • Neuroendocrine Tumors
  • Methylation analysis
  • Basel, Basel Stadt, Switzerland
    University Hospital Basel, Department of Endocrinology
May 17, 2022

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

Neuroendocrine Tumors Trial in São Paulo (MIBG-I131)

Withdrawn
  • Neuroendocrine Tumors
  • MIBG-I131
  • São Paulo, SP, Brazil
    AC Camargo Cancer Center
May 13, 2022

Neuroendocrine Tumors Trial in Australia (64Cu-SARTATE)

Recruiting
  • Neuroendocrine Tumors
  • Kingswood, New South Wales, Australia
  • +3 more
May 17, 2022

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor

Recruiting
  • PET / CT
  • +3 more
  • 68Ga-DOTA-TATE PET/MR and PET/CT imaging
  • Wuhan, Hubei, China
    China, Hubei Province
Apr 26, 2022

Neuroendocrine Tumors Trial in United States (Octreotide, LAR Lanreotide, Questionnaires)

Active, not recruiting
  • Neuroendocrine Tumors
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2022

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN

Recruiting
  • Neuroendocrine Tumors
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Apr 16, 2022

    Neuroendocrine Tumors Trial in Edmonton (68Ga-HA-DOTATATE)

    Recruiting
    • Neuroendocrine Tumors
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 11, 2022

    Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease Trial in Edmonton (18F-DOPA, Furosemide Injection)

    Recruiting
    • Congenital Hyperinsulinism
    • +5 more
    • Edmonton, Alberta, Canada
      WC Mackenzie Health Science Centre / University of Alberta Hospi
    Apr 11, 2022

    Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

    Recruiting
    • Metastatic Solid Tumor
    • +6 more
    • Surufatinib and Tislelizumab _ Part 1
    • Surufatinib and Tislelizumab _ Part 2
    • Tucson, Arizona
    • +17 more
    Apr 1, 2022

    Neuroendocrine Tumors Trial in New York (radiation, device, other)

    Recruiting
    • Neuroendocrine Tumors
    • 18F-MFBG (meta-fluoro benzylguanidine)
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 31, 2022

    Neuroendocrine Tumors Trial in Worldwide (Satoreotide tetraxetan, Amino acid solution, Antiemetic)

    Terminated
    • Neuroendocrine Tumors
    • Satoreotide tetraxetan
    • +2 more
    • Houston, Texas
    • +8 more
    Mar 16, 2022

    Neuroendocrine Tumors Trial in Iowa City ([90]Y-DOTATOC)

    Suspended
    • Neuroendocrine Tumors
    • Iowa City, Iowa
      The Holden Comprehensive Cancer Center
    Mar 8, 2022

    Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)

    Recruiting
    • Neuroendocrine Tumors
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center
    Mar 16, 2022

    Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Oxaliplatin-based chemotherapy
    • Alkylating-based chemotherapy
    • Amiens, France
    • +18 more
    Mar 15, 2022

    Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))

    Recruiting
    • Neuroendocrine Tumors
    • Liver Metastases
    • TheraSpheres Selective Internal Radiation Therapy (SIRT)
    • London, United Kingdom
      Imperial College NHS Trust
    Mar 8, 2022

    Neuroendocrine Tumors Trial in Edegem, Sint-Niklaas, Nicosia (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))

    Recruiting
    • Neuroendocrine Tumors
    • Liquid biopsies
    • Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
    • Edegem, Antwerp, Belgium
    • +2 more
    Feb 24, 2022

    Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

    Withdrawn
    • Neuroendocrine Tumors
    • +2 more
    • Telotristat ethyl
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospital and Clinics
    Feb 9, 2022

    Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

    Recruiting
    • Pancreatic Cancer
    • +49 more
      • Colorado Springs, Colorado
      • +80 more
      Feb 22, 2022

      Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

      Active, not recruiting
      • Neuroendocrine Tumors
      • Boston, Massachusetts
      • +4 more
      Feb 22, 2022

      Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

      Not yet recruiting
      • Neuroendocrine Tumors
      • Portland, Oregon
        Providence Portland Cancer Institute - Franz Clinic
      Feb 10, 2022

      Preoperative Imaging in Small Bowel Neuroendocrine Tumors

      Recruiting
      • Neuroendocrine Tumors
      • +2 more
      • preoperative imaging
      • Nancy, France
      • +1 more
      Feb 9, 2022

      Neuroendocrine Tumors Trial in Leuven (Al18F-NOTA-octreotide, PET/CT, PET/MR)

      Completed
      • Neuroendocrine Tumors
      • Leuven, Belgium
        Universitaire Ziekenhuizen Leuven
      Feb 16, 2022